- Filed
- May 8, 2024 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 3, 2024 | 27.61M sh |
| Long Term Debt | Q1 2024 · Mar 29, 2024 | $30.73M |
| Long Term Debt | Q1 2024 · Dec 29, 2023 | $32.71M |
| Cash And Equivalents | Q1 2024 · Mar 29, 2024 | $12.96M |
| Cash And Equivalents | Q1 2024 · Dec 29, 2023 | $20.96M |
| Current Liabilities | Q1 2024 · Mar 29, 2024 | $44.3M |
| Current Liabilities | Q1 2024 · Dec 29, 2023 | $49.89M |
| Total Liabilities | Q1 2024 · Mar 29, 2024 | $85.84M |
| Total Liabilities | Q1 2024 · Dec 29, 2023 | $91.35M |
| Current Assets | Q1 2024 · Mar 29, 2024 | $73.67M |
| Current Assets | Q1 2024 · Dec 29, 2023 | $75.44M |
| Total Assets | Q1 2024 · Mar 29, 2024 | $179.32M |
| Total Assets | Q1 2024 · Dec 29, 2023 | $181.43M |
| Gross Profit | Q1 2024 · Mar 29, 2024 | $20.2M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $19.49M |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 27.27M sh |
| Stock Repurchased restated | Q1 2024 · Mar 31, 2023 | $711K |
| Capex | Q1 2024 · Mar 31, 2023 | $1.06M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$3.06M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $63.44M |
| Stockholders Equity | Q1 2024 · Dec 30, 2022 | $58.28M |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.30 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.30 |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $15.44M |
| Net Income | Q1 2024 · Mar 31, 2023 | $8.16M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $11.25M |
| Revenue | Q1 2024 · Mar 31, 2023 | $71.23M |